Proceedings of the 37th Annual General Meeting held on Saturday, September 27, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Limited held its 37th AGM on September 27, 2025, via video conferencing, with 46 members present. The meeting was chaired by Mr. Ghanshyam Jaju, with all directors and KMPs attending remotely. Six resolutions were put to vote, including approval of FY25 audited financial statements, re-appointment of Mr. Mukund Kakani (who retires by rotation), appointment of Mrs. Shilpa Bung as Independent Director, ratification of Cost Auditors' remuneration, appointment of VSS & Associates as Secretarial Auditors for FY26-FY30, and a proposal to increase the Authorised Share Capital from ₹10 crore to ₹20 crore (creating 1 crore additional equity shares of ₹10 each). The Auditor's Report had no qualifications. Consolidated voting results were to be filed with BSE within 2 working days.
The most material item is the proposed doubling of authorised share capital to ₹20 crore, which gives the company flexibility to raise fresh equity or issue bonus shares in the future. The appointment of a new secretarial auditor for a 5-year term and uncontested approval of FY25 financials suggest stable governance with no major shareholder concerns raised.